GILD May 2024 62.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 12:09PM EDT. Market open.
| Previous Close | 4.8000 |
| Open | 4.7000 |
| Bid | 5.0000 |
| Ask | 5.2000 |
| Strike | 62.50 |
| Expire Date | 2024-05-17 |
| Day's Range | 4.6700 - 4.8000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 93 |
Business WireKite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
SANTA MONICA, Calif., May 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the upcoming 2024 European Hematology Association (EHA) Annual Congress, June 13-16, Madrid, Spain.
ACCESSWIREGilead Sciences: Native Health Navigator Program Connects Tribes to Cancer Care
NORTHAMPTON, MA / ACCESSWIRE / May 14, 2024 / Olivia Sloan was pursuing a career in health policy and research when her father was diagnosed with non-Hodgkin lymphoma. The devastating news put her work on hold as she returned home to Santa Fe, New ...
Yahoo FinanceOne stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
© 2024 Yahoo. All rights reserved.